Penn joins BioNTech and OUP to launch $50 million PxB Fund

9 January 2026

Thierry Heles

a walkway with a sign reading “University of Pennsylvania"

Photo: ajay_suresh via Wikimedia Commons

The University of Pennsylvania is joining forces with spinout-focused venture capital firm Osage University Partners and mRNA-based therapies developer BioNTech to launch a $50 million early-stage fund.

Keep reading with a free account. Sign up today.
Already a subscriber? Log in.

Found this useful? Share it with colleagues now.

Thierry Heles is the founder and editor of The Next Leap. He has been writing about innovation ecosystems for over 12 years. His research has featured in the UK Spinout Review and University-Investor Review, the Financial Times, and the Wall Street Journal, among others.